Abbott Laboratories
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Abbott Laboratories (ABT) Business News
Track Abbott Laboratories in real time with a live news feed covering Abbott Laboratories stock news, official press releases, company announcements, and an archive of historical Abbott Laboratories news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Best Dividend Aristocrats For March 2026
Aster Capital Management DIFC Ltd Invests $2.92 Million in Abbott Laboratories $ABT
DNB Asset Management AS Reduces Holdings in Abbott Laboratories $ABT
Andra AP fonden Invests $42.72 Million in Abbott Laboratories $ABT
Intuitive Surgical or Abbott: Which MedTech Stock Is a Better Bet Now?
Abbott's Meltdown Is Worth Buying, Compelling, Profitable Growth Prospects
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time
Abbott (ABT) Reports Q4 Earnings: What Key Metrics Have to Say
Alliance Wealth Advisors LLC UT Has $2.44 Million Position in Abbott Laboratories $ABT
Abbott declares 409th consecutive quarterly dividend
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY and 39 posting double-digit gains this year already. Dividend growth is lagging, with 2026's average increase currently at 3.
22%, below last year's trend and potentially signaling headwinds.
Best Dividend Aristocrats For March 2026
Seeking AlphaThe ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY and 39 posting double-digit gains this year already. Dividend growth is lagging, with 2026's average increase currently at 3.
22%, below last year's trend and potentially signaling headwinds.
Aster Capital Management DIFC Ltd Invests $2.92 Million in Abbott Laboratories $ABT
Defense WorldAster Capital Management DIFC Ltd acquired a new position in shares of Abbott Laboratories (NYSE: ABT) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 21,796 shares of the healthcare product maker's stock, valued at approximately $2,919,000. Abbott Laboratories comprises about 1.5% of
Read full article
DNB Asset Management AS Reduces Holdings in Abbott Laboratories $ABT
Defense WorldDNB Asset Management AS reduced its position in Abbott Laboratories (NYSE: ABT) by 6.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 464,128 shares of the healthcare product maker's stock after selling 34,333 shares during the period. DNB
Read full article
Andra AP fonden Invests $42.72 Million in Abbott Laboratories $ABT
Defense WorldAndra AP fonden purchased a new stake in Abbott Laboratories (NYSE: ABT) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 318,908 shares of the healthcare product maker's stock, valued at approximately $42,715,000. Several other hedge funds and other institutional investors
Read full article
Intuitive Surgical or Abbott: Which MedTech Stock Is a Better Bet Now?
Zacks Investment ResearchBoth ISRG and ABT closed 2025 on a strong note, but Intuitive Surgical's surging procedure growth and innovation may give it the edge for long-term gains.
Read full article
Abbott's Meltdown Is Worth Buying, Compelling, Profitable Growth Prospects
Seeking AlphaAbbott's Meltdown Is Worth Buying, Compelling, Profitable Growth Prospects
Read full article
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time
The Motley FoolAbbott Labs has raised its dividends for 54 consecutive years. The company expects earnings growth from its acquisition of Exact Sciences.
Read full article
Abbott (ABT) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks Investment ResearchWhile the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read full article
Alliance Wealth Advisors LLC UT Has $2.44 Million Position in Abbott Laboratories $ABT
Defense WorldAlliance Wealth Advisors LLC UT lowered its stake in Abbott Laboratories (NYSE: ABT) by 30.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,225 shares of the healthcare product maker's stock after selling 8,086 shares during the quarter. Alliance
Read full article
Abbott declares 409th consecutive quarterly dividend
PRNewsWireABBOTT PARK, Ill., Feb. 20, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.
Read full article